231 related articles for article (PubMed ID: 19360292)
1. Evidence of ubiquitous in vivo and in vitro expression of pro-apoptotic Smac/DIABLO protein in meningioma cell lines.
Pfister C; Ritz R; Endemann E; Schittenhelm J; Bornemann A; Tatagiba MS; Roser F
Oncol Rep; 2009 May; 21(5):1181-8. PubMed ID: 19360292
[TBL] [Abstract][Full Text] [Related]
2. Are there attacking points in the eicosanoid cascade for chemotherapeutic options in benign meningiomas?
Pfister C; Ritz R; Pfrommer H; Bornemann A; Tatagiba MS; Roser F
Neurosurg Focus; 2007; 23(4):E8. PubMed ID: 17961045
[TBL] [Abstract][Full Text] [Related]
3. A New Role for the Mitochondrial Pro-apoptotic Protein SMAC/Diablo in Phospholipid Synthesis Associated with Tumorigenesis.
Paul A; Krelin Y; Arif T; Jeger R; Shoshan-Barmatz V
Mol Ther; 2018 Mar; 26(3):680-694. PubMed ID: 29396267
[TBL] [Abstract][Full Text] [Related]
4. Rapid induction of IAP family proteins and Smac/DIABLO expression after proapoptotic stimulation with doxorubicin in RPMI 8226 multiple myeloma cells.
Abe S; Hasegawa M; Yamamoto K; Kurata M; Nakagawa Y; Suzuki K; Takizawa T; Kitagawa M
Exp Mol Pathol; 2007 Dec; 83(3):405-12. PubMed ID: 17521628
[TBL] [Abstract][Full Text] [Related]
5. Reciprocal expression of survivin and SMAC/DIABLO in primary breast cancer.
Mansour A; Nabil M; Ali-Labib R; Said H; Annos F
Med Oncol; 2012 Dec; 29(4):2535-42. PubMed ID: 22161156
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance.
Mizutani Y; Nakanishi H; Yamamoto K; Li YN; Matsubara H; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
J Clin Oncol; 2005 Jan; 23(3):448-54. PubMed ID: 15572731
[TBL] [Abstract][Full Text] [Related]
7. Smac/DIABLO regulates the apoptosis of hypertrophic scar fibroblasts.
Liu BH; Chen L; Li SR; Wang ZX; Cheng WG
Int J Mol Med; 2013 Sep; 32(3):615-22. PubMed ID: 23857156
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of Smac/DIABLO expression in colorectal cancer.
Endo K; Kohnoe S; Watanabe A; Tashiro H; Sakata H; Morita M; Kakeji Y; Maehara Y
Oncol Rep; 2009 Feb; 21(2):351-5. PubMed ID: 19148507
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application.
Ragel BT; Jensen RL; Gillespie DL; Prescott SM; Couldwell WT
J Neurosurg; 2005 Sep; 103(3):508-17. PubMed ID: 16235684
[TBL] [Abstract][Full Text] [Related]
10. Expression of Smac/DIABLO in B-cell non-Hodgkin and Hodgkin lymphomas.
Ren Y; Akyurek N; Schlette E; Rassidakis GZ; Medeiros LJ
Hum Pathol; 2006 Nov; 37(11):1407-13. PubMed ID: 16949641
[TBL] [Abstract][Full Text] [Related]
11. High Smac/DIABLO expression is associated with early local recurrence of cervical cancer.
Arellano-Llamas A; Garcia FJ; Perez D; Cantu D; Espinosa M; De la Garza JG; Maldonado V; Melendez-Zajgla J
BMC Cancer; 2006 Oct; 6():256. PubMed ID: 17067390
[TBL] [Abstract][Full Text] [Related]
12. Transfection of Smac/DIABLO sensitizes drug-resistant tumor cells to TRAIL or paclitaxel-induced apoptosis in vitro.
Mao HL; Liu PS; Zheng JF; Zhang PH; Zhou LG; Xin G; Liu C
Pharmacol Res; 2007 Dec; 56(6):483-92. PubMed ID: 18029193
[TBL] [Abstract][Full Text] [Related]
13. Relationship between expression of Smac and Survivin and apoptosis of primary hepatocellular carcinoma.
Bao ST; Gui SQ; Lin MS
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):580-3. PubMed ID: 17085346
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of Smac/DIABLO expression in human carcinomas and sarcomas.
Yoo NJ; Kim HS; Kim SY; Park WS; Park CH; Jeon H; Jung ES; Lee JY; Lee SH
APMIS; 2003 Mar; 111(3):382-8. PubMed ID: 12752217
[TBL] [Abstract][Full Text] [Related]
15. miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells.
Kliese N; Gobrecht P; Pachow D; Andrae N; Wilisch-Neumann A; Kirches E; Riek-Burchardt M; Angenstein F; Reifenberger G; Riemenschneider MJ; Meese E; Panayotova-Dimitrova D; Gutmann DH; Mawrin C
Oncogene; 2013 Sep; 32(39):4712-20. PubMed ID: 23108408
[TBL] [Abstract][Full Text] [Related]
16. Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis.
Song Z; Yao X; Wu M
J Biol Chem; 2003 Jun; 278(25):23130-40. PubMed ID: 12660240
[TBL] [Abstract][Full Text] [Related]
17. Immunoexpression of inhibitors of apoptosis proteins and their antagonist SMAC/DIABLO in colorectal carcinoma: correlation with apoptotic index, cellular proliferation and prognosis.
De Oliveira Lima F; De Oliveira Costa H; Barrezueta LF; Fujiyama Oshima CT; Silva JA; Gomes TS; Pinheiro N; Neto RA; Franco M
Oncol Rep; 2009 Aug; 22(2):295-303. PubMed ID: 19578769
[TBL] [Abstract][Full Text] [Related]
18. [Increase of BIRC5 gene expression in non-small cell lung cancer and esophageal squamous cell carcinoma does not correlate with expression of genes SMAC/DIABLO and PML encoding its inhibitors].
Vaĭshlia NA; Zinov'eva MV; Sass AV; Kopantsev EP; Vinogradova TV; Sverdlov ED
Mol Biol (Mosk); 2008; 42(4):652-61. PubMed ID: 18856066
[TBL] [Abstract][Full Text] [Related]
19. The expression of survivin and Ki-67 in meningiomas: correlation with grade and clinical outcome.
Kayaselçuk F; Zorludemir S; Bal N; Erdogan B; Erdogan S; Erman T
J Neurooncol; 2004; 67(1-2):209-14. PubMed ID: 15072469
[TBL] [Abstract][Full Text] [Related]
20. CXCR4 and SDF1 expression in human meningiomas: a proliferative role in tumoral meningothelial cells in vitro.
Bajetto A; Barbieri F; Pattarozzi A; Dorcaratto A; Porcile C; Ravetti JL; Zona G; Spaziante R; Schettini G; Florio T
Neuro Oncol; 2007 Jan; 9(1):3-11. PubMed ID: 17108064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
